Literature DB >> 25378578

Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.

Jennifer L Lyons1, Kiran T Thakur2, Rick Lee3, Tonya Watkins4, Carlos A Pardo2, Kathryn A Carson5, Barbara Markley6, Malcolm A Finkelman6, Kieren A Marr7, Karen L Roos8, Sean X Zhang9.   

Abstract

(1-3)-β-d-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25378578      PMCID： PMC4290946          DOI： 10.1128/JCM.02301-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis.

Authors:  Jennifer L Lyons; Karen L Roos; Kieren A Marr; Henry Neumann; Julie B Trivedi; Dorlan J Kimbrough; Lisa Steiner; Kiran T Thakur; Daniel M Harrison; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

2.  (1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections.

Authors:  Malgorzata Mikulska; Elisa Furfaro; Valerio Del Bono; Anna Maria Raiola; Carmen Di Grazia; Andrea Bacigalupo; Claudio Viscoli
Journal:  Clin Infect Dis       Date:  2013-02-07       Impact factor: 9.079

3.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

4.  Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.

Authors:  Anastasia P Litvintseva; Mark D Lindsley; Lalitha Gade; Rachel Smith; Tom Chiller; Jennifer L Lyons; Kiran T Thakur; Sean X Zhang; Dale E Grgurich; Thomas M Kerkering; Mary E Brandt; Benjamin J Park
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

5.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Jerry W Pickering; Howard W Sant; Catherine A P Bowles; William L Roberts; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

6.  Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-10-19       Impact factor: 17.586

7.  Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.

Authors:  T Miyazaki; S Kohno; K Mitsutake; S Maesaki; K Tanaka; N Ishikawa; K Hara
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

8.  Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

Authors:  Taminori Obayashi; Kumiko Negishi; Tomokazu Suzuki; Nobuaki Funata
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; William W Hope; Diana Mickiene; Amy M Kelaher; Heidi A Murray; Christine Mya-San; Johanna E Hughes; Margaret P Cotton; John Bacher; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191
View more
  19 in total

Review 1.  Invasive Candida Infections in the ICU: Diagnosis and Therapy.

Authors:  Péter Hankovszky; Domokos Társy; Nándor Öveges; Zsolt Molnár
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

Review 2.  Chronic Meningitis.

Authors:  Kiran T Thakur; Michael R Wilson
Journal:  Continuum (Minneap Minn)       Date:  2018-10

Review 3.  Updates in Laboratory Diagnostics for Invasive Fungal Infections.

Authors:  David Terrero-Salcedo; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

4.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

5.  Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.

Authors:  Thein Myint; Felicia C Chow; Karen C Bloch; Luke Raymond-Guillen; Thomas E Davis; Patty W Wright; Laila Woc-Colburn; Raed N Khairy; Alan C Street; Tomotaka Yamamoto; Amanda Albers; L Joseph Wheat; Chadi A Hage
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

6.  Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review.

Authors:  Christian Davis; L Joseph Wheat; Thein Myint; David R Boulware; Nathan C Bahr
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

7.  Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.

Authors:  David A Stevens; Yonglong Zhang; Malcolm A Finkelman; Demosthenes Pappagianis; Karl V Clemons; Marife Martinez
Journal:  J Clin Microbiol       Date:  2016-08-24       Impact factor: 5.948

8.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 9.  Laboratory Diagnosis of Central Nervous System Infection.

Authors:  Taojun He; Samuel Kaplan; Mini Kamboj; Yi-Wei Tang
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

Review 10.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.